Taylor & Francis announce iOpenAccess - giving authors the choice

Released : 28 September 2006

Taylor & Francis are today delighted to announce the introduction of an “iOpenAccess” option for authors publishing in 175 journals from T&F’s Chemistry, Mathematics and Physics portfolios, one behavioural science journal from Psychology Press, and medical and bioscience journals from Informa Healthcare.

From October 2006, all authors whose manuscripts are accepted for publication in one of the iOpenAccess journals will have the option to make their articles freely available to all via the Journal’s website for a one-off fee of $3100.

Commenting on the launch of the initiative, Journals Publishing Director, Dr David Green, stated: "Taylor & Francis has a strong tradition of meeting the needs of the academic and scientific research communities over more than two centuries. We are introducing iOpenAccess only after the widest possible consultation with the editor, author and funder communities. We are doing so in a manner which will continue to guarantee the integrity of peer review and the rights of authors, and which will ensure the continuing viability and quality of major international journals with whose publishing stewardship we are entrusted."

Mark Walport, Director of the Wellcome Trust, commented: "I am very pleased that Taylor and Francis are now offering an open access choice to publish in their journals. We all want to maximise the impact of biomedical research. Ensuring the widest distribution of the results of biomedical research is a key part of achieving that aim.

• Authors will be asked to grant a publishing licence or assign copyright in the normal way. Selection of the iOpenAccess option and payment of the appropriate fee will then allow the article to be made available to all under a Creative Commons Licence (Attribution-Non-commercial-No Derivatives version 2.5 ) . Under this licence we will allow tagging and cross-referencing of articles within repositories so that they relate back to the original research grants and programmes.
• Authors selecting the iOpenAccess option will have no embargo restriction on posting their version of the published article to any institutional or subject repository. Where appropriate, we will facilitate deposit on behalf of authors into PubMedCentral.
• We undertake to review the subscription prices of each journal with respect to the uptake of the iOpenAccess initiative, and the relevant information will be published on each journal’s home page at www.tandf.co.uk/journals.

Our commitment to stringent, independent, expert peer review remains: only accepted articles are eligible for the scheme, and authors will only be offered the open access option when they are sent their proofs for review. This complete separation of payment from the peer review and acceptance process will ensure that editorial independence and quality are not compromised.

This initiative is a pilot 'hybrid' open access scheme in selected subjects, and comes after the experience of a number of years' experimentation with access schemes operated by various T&F journals, as well as wide consultation with our editors, society partners and research funders. We intend to increase the number of iOpenAccess journals over the coming months, and fees may vary as we expand this initiative into other subject areas.

Taylor & Francis has a justified reputation as a leading publisher and trusted partner of learned societies for over 200 years. Through a combination of organic growth and acquisitions it has become one of the world's leading imprints for academic books and journals. The name Taylor & Francis has long been associated with a pre-eminent tradition of scholarly science publishing.

Taylor & Francis Group
www.tandf.co.uk/journals

Investors

• Company
• News & Events
• Share Information
• Financial Analysis
• Reports & Presentations
• News & Press releases
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2001 / 2002
  • 1998 / 1999 / 2000